Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Revenue

Central Pharmaceuticals had revenue of 8.93M BDT in the quarter ending September 30, 2025, a decrease of -79.29%. This brings the company's revenue in the last twelve months to 33.51M, down -70.02% year-over-year. In the fiscal year ending June 30, 2025, Central Pharmaceuticals had annual revenue of 33.06M with 11.68% growth.

• Revenue (ttm): 33.51M
• Revenue Growth: -70.02%
• P/S Ratio: 29.32
• Revenue / Employee: 446.74K
• Employees: 76
• Market Cap: 982.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	33.06M	3.46M	11.68%
Jun 30, 2024	29.60M	271.46K	0.93%
Jun 30, 2023	29.33M	3.33M	12.81%
Jun 30, 2022	26.00M	-122.15M	-82.45%
Jun 30, 2021	148.15M	8.06M	5.75%